Cardiovascular effects of the novel Ca2+-sensitiser EMD 57033 in pigs at rest and during treadmill exercise

British Journal of Pharmacology

Volumn 122, Issue 7, 1997, Pages 1257-1270

  Stubenitsky, René ^a   Van Der Weerd, Rick W P ^a   Haitsma, David B ^a   Verdouw, Pieter D ^a   Duncker, Dirk J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Adrenergic receptor blockade; Awake swine; Ca2+ sensitization; Coronary circulation; EMD 57033; Exercise; Haemodynamics; Phosphodiesterase inhibition; Pulmonary circulation; Systemic circulation

Indexed keywords

5 [1 (3,4 DIMETHOXYBENZOYL) 1,2,3,4 TETRAHYDRO 6 QUINOLYL] 3,6 DIHYDRO 6 METHYL 2H 1,3,4 THIADIAZIN 2 ONE; CALCIUM CHANNEL STIMULATING AGENT; PHOSPHODIESTERASE INHIBITOR; PIMOBENDAN;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR EFFECT; CORONARY HEMODYNAMICS; CORONARY VASCULAR RESISTANCE; FEMALE; HEART RATE; HEART STROKE VOLUME; INOTROPISM; INTRAVENOUS DRUG ADMINISTRATION; LUNG HEMODYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC VASCULAR RESISTANCE; TREADMILL EXERCISE;

EID: 0030809798     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701491     Document Type: Article

References (32)

1. BASSENGE, E. (1995). Control of coronary blood flow by autacoids. Basic Res. Cardiol., 90, 125-141.
2. 1 receptor down-regulation in heart failure. Circ. Res., 59, 297-309.
3. BRISTOW, M.R., HARRISON, D.C. & STINSON, E.B. (1982). Decreased catecholamine sensitivity and β-adrenergic receptor density in failing human hearts. N. Eng. J. Med., 307, 205-211.
4. COLUCCI, W.S., DENNISS, A.R., LEATHERMAN, G.F., QUIGG, R.J., LUDMER, P.L., MARSH, J.D. & GAUTHIER, D.F. (1988). Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition. J. Clin. Invest., 81, 1103-1110.
5. COLUCCI, W.S., RIBEIRO, J.P., ROCCO, M.B., QUIGG R.J., CREAGER, M.A., MARSH, J.D., GAUTHIER, D.F. & HARTLEY, L.H. (1989). Impaired chronotropic response to exercise in patients with congestive heart failure. Role of postsynaptic β-adrenergic desensitization. Circulation, 80, 314-323.
6. DUNCKER, D.J., HARTOG, J.M., LEVINSKY, L. & VERDOUW, P.D. (1987a) Systemic haemodynamic actions of pimobendan (UD-CG 115 BS) and its O-demethylmetabolite UD-CG 212 Cl in the conscious pig. Br. J. Pharmacol., 91, 609-615.
7. DUNCKER, D.J., SAXENA, P.R. & VERDOUW, P.D. (1987b). Systemic haemodynamic and beta-adrenoceptor antagonistic effects of bisoprolol in conscious pigs: a comparison with propranolol. Arch. Int. Pharmacol. Ther., 290, 54-63.
8. 2+ mediated through alpha- and beta-adrenoceptors. Circ. Res., 62, 247-265.
9. GROSS, T., LUES, I. & DAUT, J. (1993) A new cardiotonic drug reduces the energy cost of active tension in cardiac muscle. J. Mol. Cell. Cardiol., 25, 239-244.
10. HAIKALA, H. & LINDÉN, I.B. (1995). Mechanisms of actions of calcium-sensitizing drugs. J. Cardiovasc. Pharmacol., 26 (Suppl. 1), S10-S19.
11. HARKIN, C.P., PAGEL, P.S., TESSMER, J.P. & WARLTIER, D.C. (1995). Systemic and coronary hemodynamic actions and left ventricular functional effects of Levosimendan in conscious dogs. J. Cardiovasc. Pharmacol., 26, 179-188.
12. HARTOG, J.M., SAXENA, P.R. & VERDOUW, P.D. (1986) Inotropic and vasodilating properties of amrinone depend on the mode of administration. Eur. Heart J., 7, 1067-1076.
13. HERZIG, J.W., KOHLER, G., PFITZER, G., RÜEGG, J.C. & WOLFFLE, G. (1981). Cyclic AMP inhibits contractility of detergent treated glycerol extracted cardiac musle. Pflügers Arch., 391, 208-212.
14. HOLUBARSCH, C., HASENFUSS, G., JUST, H., BLANCHARD, E., MULIERI, L.A. & ALPERT, N.R. (1989). Influence of the positive inotropic substance pimobendan (UD-CG 115 BS) on contractile economy of guinea pig papillary muscles. J. Cardiovasc. Pharmacol., 14 (Suppl 2), S13-S17.
15. ISHIDA, T., LEWIS, R.M., HARLEY, C.J., ENTMAN, M.L. & FIELD, J.B. (1983). Comparison of hepatic extraction of insulin and glucagon in conscious and anesthetized dogs. Endocrinology, 112, 1098-1109.
16. KATZ, A.M. (1986). Potential deleterious effects of inotropic agents in the therapy of chronic heart failure. Circulation, 73 (Suppl III), III-184-III-190.
17. KRAMS, R., DUNCKER, D.J., MCFALLS, E.O., HOGENDOORN, A. & VERDOUW, P.D. (1993). Dobutamine restores the reduced efficiency of energy transfer from total mechanical work to external mechanical work in regionally stunned myocardium. Cardiovasc. Res., 27, 740-774.
18. KUBO, S.H. (1994). Inotropic agents with calcium-senstizing properties: clinical and hemodynamic effects of pimobendan. Coron. Artery Dis., 5, 119-126.
19. LILLEBERG, J., SUNDBERG, S., HÄYHÄ, M. & AKKILA, J. (1994). Haemodynamic dose-efficacy of levosimendan in healthy volunteers. Eur. J. Clin. Pharmacol., 47, 267-274.
20. LUES, I., BEIER, N., JONAS, R., KLOCKOW, M. & HAEUSLER, G. (1993). The two mechanisms of action of racemic cardiotonic EMD 53998, calcium sensitization and phosphodiesterase inhibition, reside in different enantiomers. J. Cardiovasc. Pharmacol., 231, 883-892.
21. NANKERVIS, R., LUES, I. & BROWN, L. (1994). Calcium Sensitization as a positive inotropic mechanism in diseased rat and human heart. J. Cardiovasc. Pharmacol., 24, 612-617.
22. OLSSON, R.A., BÜNGER, R. & SPAAN, J.A.E. (1991). Coronary circulation. In: The Heart and Cardiovascular System Scientific Foundations ed. Fozzard, H.A., Haber, E., Jennings, R.B., Katz, A.M. & Morgan, H.W., pp. 1393-1425. New York: Raven Press.
23. PAN, B.S. & JOHNSON, R.G. Jr (1996). Interaction of cardiotonic thiadiazinone derivatives with cardiac troponin C. J. Biol. Chem., 271, 817-823.
24. 2+ sensitization. Mol. Cell. Biochem., 157, 245-249.
25. RÜEGG, J.C. & SOLARO, R. (1993). Calcium-sensitizing positive inotropic drugs. In Heart Failure, Basic Science and Clinical Aspects, ed. Gwathmey, J.K., Briggs, G.M. & Allen, P.D. pp. 457 New York: M. Dekker Inc.
26. SOLARO, R.J., GAMBASSI, G., WARSHAW, D.M., KELLER, M.R., SPURGEON, H.A., BEIER, N. & LAKATTA, E.G. (1993). Stereoselective actions of thiadiazinones on canine cardiac myocytes and myofilaments. Circ. Res., 73, 981-990.
27. SUNDBERG, S., LILLEBERG, J., NIEMINEN, M.S. & LEHTONEN, L. (1995). Hemodynamic and neurohumoral effects of Levosimendan, a new calcium sensitizer, at rest and during exercise in healthy men. Am. J. Cardiol., 75, 1061-1066.
28. TERZIC, A., PUCEAT, M., CLEMENT, O., SCAMPS, F. & VASSORT, G. (1992). Alpha 1-adrenergic effects on intracellular pH and calcium and on myofilaments in single rat cardiac cells. J. Physiol., 447, 275-292.
29. VAN DER GIESSEN, W.J., VAN WOERKENS, L.J., DUNCKER, D.J., ROELANDT, J.R.T.C. & VERDOUW, P.D. (1989). Acute hemodynamic effects of nisoldipine and pimobendan in conscious pigs with chronic heart failure. J. Cardiovasc. Pharmacol., 14, 653-658.
30. 2+ sensitization and phosphodiesterase III inhibitory effects in guinea pig myocardium. Circ. Res., 70, 1081-1090.
31. VERDOUW, P.D., DUNCKER, D.J. & SAXENA, P.R. (1984). Poor vasoconstrictor response to adrenergic stimulation in the arteriovenous anastomoses present in the carotid vascular bed of young Yorkshire pigs. Arch. Int. Pharmacol. Thér., 272, 56-70.
32. 2+ in isolated ferret cardiac muscle. Circ. Res., 73, 61-70.